These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

481 related articles for article (PubMed ID: 21439852)

  • 1. Hemodialysis induces p66(shc) gene expression in nondiabetic humans: correlations with oxidative stress and systemic inflammation.
    Zanetti M; Barazzoni R; Gortan Cappellari G; Burekovic I; Bosutti A; Stocca A; Bianco F; Ianche M; Panzetta G; Guarnieri G
    J Ren Nutr; 2011 Sep; 21(5):401-9. PubMed ID: 21439852
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relation between the plasma levels of LDL-cholesterol and the expression of the early marker of inflammation long pentraxin PTX3 and the stress response gene p66ShcA in pacemaker-implanted patients.
    Bosutti A; Grassi G; Zanetti M; Aleksova A; Zecchin M; Sinagra G; Biolo G; Guarnieri G
    Clin Exp Med; 2007 Mar; 7(1):16-23. PubMed ID: 17380301
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diabetes induces p66shc gene expression in human peripheral blood mononuclear cells: relationship to oxidative stress.
    Pagnin E; Fadini G; de Toni R; Tiengo A; Calò L; Avogaro A
    J Clin Endocrinol Metab; 2005 Feb; 90(2):1130-6. PubMed ID: 15562031
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic deletion of p66(Shc) adaptor protein prevents hyperglycemia-induced endothelial dysfunction and oxidative stress.
    Camici GG; Schiavoni M; Francia P; Bachschmid M; Martin-Padura I; Hersberger M; Tanner FC; Pelicci P; Volpe M; Anversa P; Lüscher TF; Cosentino F
    Proc Natl Acad Sci U S A; 2007 Mar; 104(12):5217-22. PubMed ID: 17360381
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changes in the inflammatory and oxidative stress markers during a single hemodialysis session in patients with chronic kidney disease.
    Sangeetha Lakshmi B; Harini Devi N; Suchitra MM; Srinivasa Rao PVLN; Siva Kumar V
    Ren Fail; 2018 Nov; 40(1):534-540. PubMed ID: 30277113
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma pentraxin 3 is associated with cardiovascular disease in hemodialysis patients.
    Xu Y; Ding X; Zou J; Liu Z; Jiang S; Xu S; Shen B; Chen Y; Shan Y; Cao X
    Ren Fail; 2011; 33(10):998-1004. PubMed ID: 22013933
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of hemodialysis on accelerated atherosclerosis in diabetic patients: correlation of carotid artery intima-media thickness with oxidative stress.
    Dursun B; Dursun E; Suleymanlar G; Ozben B; Capraz I; Apaydin A; Ozben T
    J Diabetes Complications; 2009; 23(4):257-64. PubMed ID: 18413174
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inflammation and oxidative stress in end-stage renal disease patients treated with hemodialysis or peritoneal dialysis.
    Filiopoulos V; Hadjiyannakos D; Takouli L; Metaxaki P; Sideris V; Vlassopoulos D
    Int J Artif Organs; 2009 Dec; 32(12):872-82. PubMed ID: 20037892
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oxidative stress influences CC-chemokine levels in hemodialyzed patients.
    Pawlak K; Pawlak D; Mysliwiec M
    Nephron Physiol; 2004; 96(4):p105-12. PubMed ID: 15122056
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationships between plasma pentraxin 3 levels and inflammation markers patients with tunneled permanent catheter in hemodialysis.
    Yigit IP; Dogukan A; Taskapan H; Comert M; Ilhan N; Ulu R; Aygen B
    J Vasc Access; 2015; 16(5):377-81. PubMed ID: 26070095
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Post-ischaemic silencing of p66Shc reduces ischaemia/reperfusion brain injury and its expression correlates to clinical outcome in stroke.
    Spescha RD; Klohs J; Semerano A; Giacalone G; Derungs RS; Reiner MF; Rodriguez Gutierrez D; Mendez-Carmona N; Glanzmann M; Savarese G; Kränkel N; Akhmedov A; Keller S; Mocharla P; Kaufmann MR; Wenger RH; Vogel J; Kulic L; Nitsch RM; Beer JH; Peruzzotti-Jametti L; Sessa M; Lüscher TF; Camici GG
    Eur Heart J; 2015 Jul; 36(25):1590-600. PubMed ID: 25904764
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protein oxidative stress and dyslipidemia in dialysis patients.
    Marques de Mattos A; Marino LV; Ovidio PP; Jordão AA; Almeida CC; Chiarello PG
    Ther Apher Dial; 2012 Feb; 16(1):68-74. PubMed ID: 22248198
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Significance of elevated gingival crevicular fluid tumor necrosis factor-alpha and interleukin-8 levels in chronic hemodialysis patients with periodontal disease.
    Dağ A; Firat ET; Kadiroğlu AK; Kale E; Yilmaz ME
    J Periodontal Res; 2010 Aug; 45(4):445-50. PubMed ID: 20337890
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selective inhibition of protein kinase C β2 attenuates the adaptor P66 Shc-mediated intestinal ischemia-reperfusion injury.
    Chen Z; Wang G; Zhai X; Hu Y; Gao D; Ma L; Yao J; Tian X
    Cell Death Dis; 2014 Apr; 5(4):e1164. PubMed ID: 24722289
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The p66shc gene expression in peripheral blood monocytes is increased in patients with coronary artery disease.
    Noda Y; Yamagishi S; Matsui T; Ueda S; Ueda S; Jinnouchi Y; Hirai Y; Imaizumi T
    Clin Cardiol; 2010 Sep; 33(9):548-52. PubMed ID: 20842738
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Systemic inflammation and oxidative stress in hemodialysis patients are associated with down-regulation of Nrf2.
    Pedruzzi LM; Cardozo LF; Daleprane JB; Stockler-Pinto MB; Monteiro EB; Leite M; Vaziri ND; Mafra D
    J Nephrol; 2015 Aug; 28(4):495-501. PubMed ID: 25585822
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reduced plasma zinc levels, lipid peroxidation, and inflammation biomarkers levels in hemodialysis patients: implications to cardiovascular mortality.
    Lobo JC; Stockler-Pinto MB; Farage NE; Faulin Tdo E; Abdalla DS; Torres JP; Velarde LG; Mafra D
    Ren Fail; 2013; 35(5):680-5. PubMed ID: 23650973
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Carotid artery intima-media thickness correlates with oxidative stress in chronic haemodialysis patients with accelerated atherosclerosis.
    Dursun B; Dursun E; Suleymanlar G; Ozben B; Capraz I; Apaydin A; Ozben T
    Nephrol Dial Transplant; 2008 May; 23(5):1697-703. PubMed ID: 18174265
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The cardioprotective effects elicited by p66(Shc) ablation demonstrate the crucial role of mitochondrial ROS formation in ischemia/reperfusion injury.
    Carpi A; Menabò R; Kaludercic N; Pelicci P; Di Lisa F; Giorgio M
    Biochim Biophys Acta; 2009 Jul; 1787(7):774-80. PubMed ID: 19362067
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Deletion of the lifespan determinant p66(Shc) improves performance in a spatial memory task, decreases levels of oxidative stress markers in the hippocampus and increases levels of the neurotrophin BDNF in adult mice.
    Berry A; Greco A; Giorgio M; Pelicci PG; de Kloet R; Alleva E; Minghetti L; Cirulli F
    Exp Gerontol; 2008 Mar; 43(3):200-8. PubMed ID: 18065182
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.